Ruthigen Inc
Ruthigen Inc. is a biopharmaceutical company based in Santa Rosa, CA, dedicated to the discovery, development, and commercialization of hypochlorous acid-based therapeutics aimed at preventing and treating infections in surgical settings. Their lead product, RUT58-60, is a broad-spectrum anti-infective designed to target various pathogens while minimizing the risk of antibiotic resistance.
The innovative formulation of RUT58-60 not only demonstrates rapid antimicrobial action but also shows promise in accelerating healing and improving recovery times for surgical patients. By integrating seamlessly into existing surgical protocols and offering a stable, ready-to-use solution, Ruthigen Inc. positions itself as a pioneering force in infection prevention within the healthcare industry.
Generated from the website